Rhinocerebral Mucormycosis as a Sequelae of COVID-19 Treatment: A Case Report & Literature Review

A large volume of reports detailing a marked increase in Mucormycosis infections in India has filtered its way into world news articles. These patients frequently have 2 risk factors: recent treatment of COVID-19 with high dose steroids, and uncontrolled diabetes. Recently, at the University of Tennessee Medical Center in Knoxville, we successfully treated an uncontrolled diabetic patient with rhinocerebral Mucormycosis as a sequela of his COVID-19 treatment.

https://www.joms.org/article/S0278-2391(21)01119-8/fulltext?rss=yes

Source: Journal of Oral and Maxillofacial Surgery - September 19, 2021 Category: ENT & OMF Authors: Andrew J. Deek, Stefanos Boukovalas, Christopher J. Rathfoot, Jack E. Gotcher Tags: Pathology Source Type: research